David Shaw’s Tonix Pharmaceuticals TNXP Stock Holding History
Bought
Maintained
Sold
Other funds holding TNXP
JHC
David Shaw's TNXP Position: Q3 2026 in Review
David Shaw opened a new position in Tonix Pharmaceuticals (TNXP) in Q3 2026: 35,294 shares worth $344K. The stake represents ﹤0.01% of the portfolio and ranks #4429 among its holdings. This is a return to the name: David Shaw previously reported a position in TNXP as recently as Q1 2022.
David Shaw first reported a position in TNXP in Q2 2021 and has held it in 5 quarters since. The position peaked at $6.68M in Q4 2021. 113 funds tracked by Wall St. Rank hold TNXP as of Q3 2026.
- David Shaw held 35,294 shares of Tonix Pharmaceuticals worth $344K as of Q3 2026.
- Tonix Pharmaceuticals was a new David Shaw position in Q3 2026.
- Tonix Pharmaceuticals made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #4429 holding.
- David Shaw first reported a position in Tonix Pharmaceuticals in Q2 2021 and has held it in 5 quarters since.
- David Shaw's Tonix Pharmaceuticals position peaked at $6.68M in Q4 2021.
- 113 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q3 2026.
Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.